Evidence-levels in pathology for informing the WHO classification of tumours
Histopathology
.
2022 Oct;81(4):420-425.
doi: 10.1111/his.14648.
Authors
Blanca Iciar Indave
1
,
Richard Colling
2
3
,
Fiona Campbell
4
,
Puay Hoon Tan
5
,
Ian A Cree
1
Affiliations
1
WHO Classification of Tumours Programme, International Agency for Research on Cancer, World Health Organisation, Lyon, France.
2
Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.
3
Department of Cellular Pathology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
4
School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.
5
Division of Pathology, Singapore General Hospital, Singapore.
PMID:
36089568
DOI:
10.1111/his.14648
No abstract available
Keywords:
WHO Classification of tumours; evidence levels; evidence-based pathology.
Publication types
Editorial
MeSH terms
Humans
Neoplasms*
World Health Organization
Grants and funding
001/WHO_/World Health Organization/International